WallStSmart

Dolby Laboratories (DLB)vsRB Global Inc. (RBA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

RB Global Inc. generates 258% more annual revenue ($4.85B vs $1.35B). DLB leads profitability with a 16.7% profit margin vs 10.0%. RBA appears more attractively valued with a PEG of 0.65. RBA earns a higher WallStSmart Score of 68/100 (B-).

DLB

Hold

44

out of 100

Grade: D

Growth: 2.7Profit: 6.5Value: 6.7Quality: 8.5
Piotroski: 3/9Altman Z: 4.85

RBA

Strong Buy

68

out of 100

Grade: B-

Growth: 8.7Profit: 6.5Value: 7.3Quality: 5.5
Piotroski: 4/9Altman Z: 1.35
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DLBUndervalued (+34.8%)

Margin of Safety

+34.8%

Fair Value

$106.02

Current Price

$61.67

$44.35 discount

UndervaluedFair: $106.02Overvalued
RBAUndervalued (+62.7%)

Margin of Safety

+62.7%

Fair Value

$305.11

Current Price

$84.41

$220.70 discount

UndervaluedFair: $305.11Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DLB3 strengths · Avg: 9.3/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.8510/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

RBA3 strengths · Avg: 8.0/10
PEG RatioValuation
0.658/10

Growing faster than its price suggests

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
34.0%8/10

Earnings expanding 34.0% YoY

Areas to Watch

DLB4 concerns · Avg: 3.3/10
PEG RatioValuation
2.084/10

Expensive relative to growth rate

P/E RatioValuation
25.5x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-3.3%2/10

Revenue declined 3.3%

RBA2 concerns · Avg: 3.0/10
P/E RatioValuation
36.3x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.352/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DLB

The strongest argument for DLB centers on Debt/Equity, Altman Z-Score, Price/Book. Profitability is solid with margins at 16.7% and operating margin at 12.6%.

Bull Case : RBA

The strongest argument for RBA centers on PEG Ratio, Price/Book, EPS Growth. Revenue growth of 11.1% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bear Case : DLB

The primary concerns for DLB are PEG Ratio, P/E Ratio, Piotroski F-Score.

Bear Case : RBA

The primary concerns for RBA are P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

DLB profiles as a declining stock while RBA is a value play — different risk/reward profiles.

DLB carries more volatility with a beta of 0.78 — expect wider price swings.

RBA is growing revenue faster at 11.1% — sustainability is the question.

DLB generates stronger free cash flow (148M), providing more financial flexibility.

Bottom Line

RBA scores higher overall (68/100 vs 44/100) and 11.1% revenue growth. DLB offers better value entry with a 34.8% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dolby Laboratories

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.

RB Global Inc.

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Ritchie Bros. The company is headquartered in Burnaby, Canada.

Want to dig deeper into these stocks?